BCL11A gene variants affect the insulin response to glucose (24) and glucagon secretion (25), thus, have been shown to increase the risk of T2D in Europeans, North African Arabs (26) and African-Americans (27). This evidence concerns the gene BCL11A and type 2 diabetes mellitus.